| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 653.39 | 662.35 | 669.97 | 562.16 |
| Accumulated Depreciation Total | -156.10 | -140.69 | -125.34 | -110.07 |
| Other Liabilities Total | 56.77 | 59.17 | 34.90 | 21.55 |
| Accrued Expenses | 7.39 | 1.11 | 0.68 | 0.53 |
| Long Term Debt | 133.37 | 181.77 | 184.81 | 164.37 |
| Common Stock Total | 8.51 | 8.51 | 8.51 | 8.51 |
| Other Equity Total | 3.67 | 3.21 | 3.19 | 1.68 |
| Other Current Assets Total | 14.89 | 15.99 | 15.58 | 1.03 |
| Prepaid Expenses | 1.68 | 1.27 | 1.28 | 2.39 |
| Total Assets | 653.39 | 662.35 | 669.97 | 562.16 |
| Current Portof LT Debt/ Capital Leases | 44.83 | 25.92 | 24.82 | 23.51 |
| Additional Paid- In Capital | 17.51 | 17.51 | 17.51 | 17.51 |
| Cash | 5.59 | 12.31 | 12.67 | 24.27 |
| Total Equity | 314.26 | 291.79 | 279.73 | 259.98 |
| Long Term Investments | 34.05 | 29.93 | 25.31 | 21.24 |
| Retained Earnings( Accumulated Deficit) | 284.57 | 262.57 | 250.52 | 232.29 |
| Total Common Shares Outstanding | 0.85 | 0.85 | 0.85 | 0.85 |
| Property/ Plant/ Equipment Total- Gross | 565.46 | 548.27 | 530.38 | 427.11 |
| Tangible Book Valueper Share Common Eq | 361.59 | 338.39 | 325.38 | 303.21 |
| Total Liabilities | 339.13 | 370.55 | 390.24 | 302.18 |
| Total Debt | 213.25 | 244.38 | 274.15 | 228.17 |
| Cashand Short Term Investments | 5.59 | 12.31 | 12.67 | 39.28 |
| Total Receivables Net | 96.51 | 102.72 | 103.75 | 69.73 |
| Notes Payable/ Short Term Debt | 29.58 | 31.35 | 58.86 | 34.85 |
| Deferred Income Tax | 5.93 | 7.41 | 7.35 | 6.51 |
| Accounts Receivable- Trade Net | 77.83 | 82.08 | 83.06 | 55.28 |
| Property/ Plant/ Equipment Total- Net | 409.35 | 407.58 | 405.04 | 317.04 |
| Minority Interest | 12.40 | 11.08 | 8.82 | 7.41 |
| Total Current Liabilities | 125.18 | 105.79 | 148.70 | 96.90 |
| Total Inventory | 76.51 | 82.34 | 94.31 | 82.34 |
| Accounts Payable | 29.42 | 26.44 | 29.98 | 18.02 |
| Other Currentliabilities Total | 13.97 | 20.97 | 34.36 | 20.00 |
| Total Long Term Debt | 138.84 | 187.11 | 190.48 | 169.81 |
| Intangibles Net | 6.66 | 3.93 | 2.94 | 2.04 |
| Other Long Term Assets Total | 5.58 | 3.79 | 4.58 | 6.06 |
| Note Receivable- Long Term | 2.57 | 2.50 | 4.51 | 21.02 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 195.17 | 214.62 | 227.59 | 194.76 |
| Capital Lease Obligations | 5.48 | 5.34 | 5.67 | 5.44 |
| Short Term Investments | - | - | - | 15.01 |
Hester Biosciences Dividend Hester Biosciences Bonus Hester Biosciences News Hester Biosciences AGM Hester Biosciences Rights Hester Biosciences Splits Hester Biosciences Board Meetings Hester Biosciences Key Metrics Hester Biosciences Shareholdings Hester Biosciences Profit Loss Hester Biosciences Cashflow Hester Biosciences Q1 Results Hester Biosciences Q2 Results Hester Biosciences Q3 Results Hester Biosciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks